Colorectal carcinoma: a general overview and future perspectives in colorectal cancer

I Mármol, C Sánchez-de-Diego… - International journal of …, 2017 - mdpi.com
Colorectal cancer (CRC) is the third most common cancer and the fourth most common
cause of cancer-related death. Most cases of CRC are detected in Western countries, with its …

[HTML][HTML] Colorectal cancer: from prevention to personalized medicine

G Binefa, F Rodríguez-Moranta, À Teule… - World journal of …, 2014 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is a very heterogeneous disease that is caused by the interaction
of genetic and environmental factors. CRC develops through a gradual accumulation of …

Cell surface protein glycosylation in cancer

MN Christiansen, J Chik, L Lee, M Anugraham… - …, 2014 - Wiley Online Library
Glycosylation of proteins is one of the most important PTMs, with more than half of all human
proteins estimated to be glycosylated. It is widely known that aberrant glycosylation has …

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

Q Shen, J Fan, XR Yang, Y Tan, W Zhao, Y Xu… - The lancet …, 2012 - thelancet.com
Background Hepatocellular carcinoma (HCC) is prevalent worldwide and improvements in
timely and effective diagnosis are needed. We assessed whether measurement of Dickkopf …

Colorectal cancer biomarkers: where are we now?

M Gonzalez-Pons… - BioMed research …, 2015 - Wiley Online Library
Colorectal cancer is one of the major causes of cancer‐related death in the Western world.
Patient survival is highly dependent on the tumor stage at the time of diagnosis. Reduced …

Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers

L Jamali, R Tofigh, S Tutunchi, G Panahi… - Journal of cellular …, 2018 - Wiley Online Library
Gastric and esophageal cancers are as main cancers of the gastrointestinal (GI) tract, which
are associated with poor diagnosis and survival. Several efforts were made in the past few …

Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas

LD Graham, SK Pedersen, GS Brown, T Ho… - Genes & …, 2011 - journals.sagepub.com
An uncharacterized gene locus (Chr16: hCG_1815491), now named colorectal neoplasia
differentially expressed (gene symbol CRNDE), is activated early in colorectal neoplasia …

Identification and evaluation of plasma microRNAs for early detection of colorectal cancer

X Luo, C Stock, B Burwinkel, H Brenner - PloS one, 2013 - journals.plos.org
Background Colorectal cancer (CRC) is one of the most commonly diagnosed cancers.
Circulating microRNAs (miRNAs) have been suggested as potentially promising markers for …

Discovery and validation of new potential biomarkers for early detection of colon cancer

X Solé, M Crous-Bou, D Cordero, D Olivares, E Guinó… - PLoS …, 2014 - journals.plos.org
Background Accurate detection of characteristic proteins secreted by colon cancer tumor
cells in biological fluids could serve as a biomarker for the disease. The aim of the present …

Evaluating the prognostic role of elevated preoperative carcinoembryonic antigen levels in colon cancer patients: results from the national cancer database

AZ Becerra, CP Probst, MA Tejani, CT Aquina… - Annals of surgical …, 2016 - Springer
Objectives Carcinoembryonic antigen (CEA) is a reliable tumor marker for the management
and surveillance of colon cancer. However, limitations in previous studies have made it …